Skip to main content
MetalloBio Logo. Link back to homepage
About
Mission and ImpactTeam
Education Resources
Documents and PublicationsInsights and Articles
Research & DevelopmentInvestorsPartnershipsNews & EventsContact
INVEST NOW

Documents and Publications

Explore our comprehensive library of documents and publications to stay informed about MetalloBio’s latest innovations and developments. From in-depth research articles to detailed investor reports, our resources provide valuable insights into our groundbreaking work in combating antimicrobial resistance.

Technical Briefs

MetalloBio Limited - Materials Partnering & Licensing Information_December 2025

This two page summary gives an overview of data generated to date in support of our Non-PHARMA programme (materials R&D; coatings, plastics and additives).

Other

Market Discovery Internship Opportunity 2025-26.

This document gives an overview of (multiple) internship opportunities available to both undergraduate and postgraduate students with MetalloBio, focused on market and product user discovery work.

Image / Photo

MetalloBio's Pipeline - Antimicrobial Candidate: KLS-219 Chemical Structure

A schematic illustrating the chemical structure of our lead Non-PHARMA programme candidate, mono-nuclear KLS-219 (Patented: WO2020201754)

Image / Photo

MetalloBio Limited - Current Therapeutic Pipeline

A graphical summary of our current drug discovery and development pipeline.

Image / Photo

MetalloBio's Pipeline - Antimicrobial Candidate: KLS-116 Chemical Structure

A schematic illustrating the chemical structure of our lead PHARMA programme candidate, di-nuclear KLS-116 (Patented: WO2020201754)
MetalloBio Logo Vertical
MetalloBio's mission is fundamentally to change the nature of antibiotics and the treatment of infections.
Mission and Impact
Research & Development
Insights and Articles
Bluesky
LinkedIn
Copyright © [current year]
Metallobio Ltd. Sheffield, United Kingdom
Contact UsInvestors Information
News and EventsPartners Information
Privacy Policy
Series 1 Compounds
Series 2 Compounds
Programme Commercialisation
Programme Commercialisation
A New Commercial Paradigm
Driving Innovation Value
Our Value Proposition
Product Pipeline
Development Timeline